Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published in Cancer Cell.
23 Dec 2021
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Researchers from the Crick and UCL, working with Genomics England, have shown that rogue genetic material called extrachromosomal DNA can drive the survival of some of the most agg… More...

Researchers at the Francis Crick Institute and UCL have embarked on a study to establish a causal link between air pollu… More...

Mouse neuron grown on coverslips. The dots of colour are individual synapses. More...

Researchers at the Crick and UCL have developed a tool to analyse a key set of genes linked to the ability of cancer cel… More...

Researchers at the Crick have shown that the balance of bacteria in the gut can influence symptoms of hypopituitarism in… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


This website is powered by
ToucanTech